Search results
Breakthrough diabetes cure might restore insulin production and reverse illness
BGR· 4 hours agoWithout fixing the pancreas’s ability to produce insulin that meets the body’s needs, you can’t cure...
AI Identifies Three Parkinson's Subtypes - Neuroscience News
Neuroscience News· 7 hours agoSummary: Researchers used machine learning to identify three subtypes of Parkinson’s disease based...
Proof-of-principle study shows protein isoform inhibitors may hold the key to making opioids safer
Medical Xpress· 8 hours agoResearchers at the University of Arizona Health Sciences identified a new way to make opioids safer,...
Many breast cancer survivors do not receive genetic testing, despite being eligible
Medical Xpress· 8 hours ago"Our findings support a rapidly growing movement to simplify clinical guidelines to increase access...
What Doctors Want You to Know About Drinking Water to Lower Blood Pressure
Prevention· 10 hours agoSince water makes up nearly 60% of the human body’s weight, it's no surprise that the amount we...
Red Deer Polytechnic celebrates scholarly activity and applied research
Red Deer Advocate· 12 hours agoRed Deer Polytechnic recently celebrated its faculty’s vast scholarly activity and independent...
Does Using a Walking Pad ‘Count’ as Working Out?
Self via Yahoo News· 14 hours agoAnd you don’t necessarily need to stroll for a sustained amount of time to make it worth it. According to a 2023 study published inMedicine & Science in...
Nutrition Facts labels have a complicated legacy – a historian explains the science and politics of...
The Conversation via Yahoo Canada News· 16 hours agoThe process of converting food into nutritional information is more than just a scientific process....
Alberta Enterprise Corporation invests US$7.5 million into Amplitude precision medicine fund
CNW· 16 hours ago/CNW/ - Alberta Enterprise Corporation (AEC) announced today that it has invested US$7.5 million into Amplitude Ventures' US$192-million Fund II to give early...
Health Canada authorizes Alecensaro® (alectinib) as the first and only adjuvant treatment for people...
CNW· 16 hours ago/CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on June 27, 2024, Health Canada granted approval of Alecensaro® (alectinib)...